In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory ...

The umbrella programme Data Driven Research to Eradicate TB (Dare2eraD TB) was launched in March 2022 and included setting up ...

Even if US foreign aid cuts are reversed, the damage to global TB control has already been done, says Saw Swee Hock School of ...

The WHO reports that tuberculosis cases in children are rising globally. Experts say a rise in TB cases in Europe could mean ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. Globally, an estimated 10.8 million people ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).

He chronicles the medical advances, most notably the arrival of effective anti-tuberculosis drugs in the 1950s, that have tamed the disease in wealthy countries. (Each year, the United States ...